Investor profile
Mission BioCapital has backed 2 European tech companies across 3 funding rounds between 2022 and 2024, joining rounds totalling €153M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 2 | €78M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| Immunos Therapeutics | Series B | €68M | 2022-06 |
| Immunos Therapeutics | Series C | €9.9M | 2024-09 |
